BTG4 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9NY30 |
---|---|
Clone Names | 110811027 |
Gene ID | 54766 |
---|---|
Other Names | Protein BTG4, BTG family member 4, Protein PC3b, BTG4, PC3B |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | BTG4 |
---|---|
Synonyms | PC3B |
Function | Adapter protein that bridges CNOT7, a catalytic subunit of the CCR4-NOT complex, to EIF4E (By similarity). Facilitates maternal mRNAs decay during the maturation of oocytes and in the fertilized egg, and is required for the maternal-zygotic transition (MZT), zygotic cleavage and initiation of embryonic development (PubMed:32502391). |
Tissue Location | Expressed in oocytes after germinal vesicle breakdown (PubMed:32502391). Expressed in testis and in olfactory epithelium. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The protein encoded by this gene is a member of theBTG/Tob family. This family has structurally related proteins thatappear to have antiproliferative properties. This encoded proteincan induce G1 arrest in the cell cycle.
References
Xu, Y., et al. Int. J. Cancer (2010) In press :Dong, W., et al. Biochem. Biophys. Res. Commun. 387(1):132-138(2009)Toyota, M., et al. Cancer Res. 68(11):4123-4132(2008)Auer, R.L., et al. Genes Chromosomes Cancer 43(1):1-10(2005)Yoshida, Y., et al. Jpn. J. Cancer Res. 92(6):592-596(2001)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.